Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2018
This was a Phase 2b, multicenter, randomized, double‐masked, placebo controlled study designed to evaluate the safety and efficacy of OC 01 nasal spray in adult subjects with DED. The study randomized 182 subjects, at least 22 years of age, who had a physician's diagnosis of dry eye disease and met all other study eligibility criteria to receive an application of OC‐01 or placebo twice daily (BID) for 4 weeks.
Epistemonikos ID: b6b9ce7ee6c2a37c6c34cc262bf8ab601c25e73c
First added on: Dec 20, 2022